Education
About Us
Working with TipRanks
Follow Us
Pharmarise Holdings Corp. (JP:2796)
:2796
2796 Stock Chart & Stats
¥523.00
-¥5.00(-0.91%)
At close: 4:00 PM EST
¥523.00
-¥5.00(-0.91%)
Day’s Range― - ―
52-Week Range¥456.00 - ¥596.00
Previous CloseN/A
Volume3.80K
Average Volume (3M)15.55K
Market Cap
¥6.14B
Enterprise Value¥16.65B
Total Cash (Recent Filing)¥2.24B
Total Debt (Recent Filing)¥14.25B
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Dec 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.66%
Share Statistics
EPS (TTM)-1.62
Shares Outstanding12,060,381
10 Day Avg. Volume9,170
30 Day Avg. Volume15,546
Financial Highlights & Ratios
PEG Ratio5.37
Price to Book (P/B)0.80
Price to Sales (P/S)0.09
P/FCF Ratio9.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Pharmarise Holdings Corp. News
2796 FAQ
What was Pharmarise Holdings Corp.’s price range in the past 12 months?
Pharmarise Holdings Corp. lowest stock price was ¥456.00 and its highest was ¥596.00 in the past 12 months.
What is Pharmarise Holdings Corp.’s market cap?
Pharmarise Holdings Corp.’s market cap is ¥6.14B.
When is Pharmarise Holdings Corp.’s upcoming earnings report date?
Pharmarise Holdings Corp.’s upcoming earnings report date is Dec 17, 2025 which is tomorrow.
How were Pharmarise Holdings Corp.’s earnings last quarter?
Pharmarise Holdings Corp. released its earnings results on Sep 25, 2025. The company reported -¥1.62 earnings per share for the quarter, missing the consensus estimate of N/A by -¥1.62.
Is Pharmarise Holdings Corp. overvalued?
According to Wall Street analysts Pharmarise Holdings Corp.’s price is currently Overvalued.
Does Pharmarise Holdings Corp. pay dividends?
Pharmarise Holdings Corp. pays a Annually dividend of ¥14 which represents an annual dividend yield of 2.66%. See more information on Pharmarise Holdings Corp. dividends here
What is Pharmarise Holdings Corp.’s EPS estimate?
Pharmarise Holdings Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmarise Holdings Corp. have?
Pharmarise Holdings Corp. has 12,060,381 shares outstanding.
What happened to Pharmarise Holdings Corp.’s price movement after its last earnings report?
Pharmarise Holdings Corp. reported an EPS of -¥1.62 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.302%.
Which hedge fund is a major shareholder of Pharmarise Holdings Corp.?
Currently, no hedge funds are holding shares in JP:2796
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pharmarise Holdings Corp.
Pharmarise Holdings Corp. (2796) is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapies for various medical conditions, particularly in the fields of oncology and rare diseases. The company operates primarily in the pharmaceutical sector, leveraging advanced technologies to create novel drug formulations and delivery systems. With a robust pipeline of products ranging from preclinical candidates to marketed drugs, Pharmarise is dedicated to improving patient outcomes through targeted treatments and personalized medicine.
Technical Analysis
Ohki Health Care Holdings, Inc.
―
SATUDORA HOLDINGS CO., LTD.
―
Medical System Network Co., Ltd.
―
Yakuodo Holdings Co., Ltd.
―
Astena Holdings Co.,Ltd.
―